Le Lézard
Classified in: Science and technology
Subjects: PDT, TRI

Trialbee Releases New Features for the Insights Module in the Honey Platformtm to Enhance ROI Analysis and Patient Recruitment Projections in Global Clinical Trials


Improved features include a full-funnel ROI calculator, recruitment targets, simplified CRA and site workflows, and additional metrics for greater understanding of progress toward goals

CHAPEL HILL, N.C., and MALMÖ, Sweden, Feb. 12, 2024 /PRNewswire-PRWeb/ -- Trialbee, the global leader in technology-based patient recruitment for clinical trials, has introduced key features for the Insights Module in its Honey Platformtm to provide even greater visibility into recruitment ROI and projections. These enhancements include...

Sponsors are making substantial investments in patient recruitment and deserve a better understanding of how their outreach is paying off

The Honey Platform already transforms patient recruitment for global trials with unprecedented transparency and actionable data analytics. These new features in its Insights Module allow sponsors to make even better data-driven decisions that improve recruitment outcomes. Matching the rest of the SaaS platform, all new features have been designed with consumer-grade UX that improves end-user adoption and satisfaction.

"Sponsors are making substantial investments in patient recruitment and deserve a better understanding of how their outreach is paying off," said Matt Walz, CEO of Trialbee. "This unparalleled level of visibility provides a thorough assessment of their efforts across all recruitment providers, sources, advocacy groups, and channels, so they can optimize their budgets accordingly. Evidence-driven knowledge of what is working, and what is not, ensures study teams identify, recruit, and enroll a wide range of candidates into their trials faster."

The ROI calculator empowers sponsors with a clear view of their results for each recruitment source, partner, channel, and individual tactic, allowing them to compare the efficiency of their outreach mix to make data-backed decisions about where to spend their time, energy, and budget.

Intuitive recruitment targets offer better visualization of progress toward global enrollment goals, with powerful performance metrics such as the number of patients referred per site per month (PSM), allowing users to evaluate their successes to date without having to dig through tabular data.

Finally, workflow improvements to the "My Candidates & Sites" dashboard ensure CRAs have the information they need at their fingertips to follow-up with sites and sends alerts of new trial candidates so they can ensure no enrollment opportunities are missed.

"What makes the Honey Platform unique is that it is the only Patient Recruitment Platform built by, used by, and surrounded by true patient recruitment experts," said Oskar Daniel, Trialbee Honey Product Manager. "Having an in-house team of demanding users who have supported literally thousands of global clinical trials ? along with the feedback we are constantly soliciting from site, sponsor, and CRO customers ? ensures we prioritize the features and usability enhancements that will make a real difference in how patient recruitment is managed. By providing total transparency and actionable insights, we help study teams improve recruitment outcomes and connect more patients to potentially life-changing clinical trial opportunities."

Trialbee Honey is a vendor-agnostic and stand-alone Patient Recruitment Platform (PRP) that centralizes activities and standardizes data formats across all recruitment sources globally, and tracks participant journeys from interest through enrollment. By creating a single funnel with meaningful visual analytics and dashboards, Honey provide unprecedented transparency, actionable data insights, and trustworthy ROI reporting. This enables sponsors to optimize budgets, evaluate partners objectively, and take control of global patient recruitment.

To experience how Trialbee is revolutionizing the patient recruitment ecosystem through technology, people, and passion, visit https://www.trialbee.com.

About Trialbee

Trialbee is revolutionizing the patient recruitment ecosystem with technology, people, and passion. The company's vendor-agnostic Honey Platformtm is a SaaS Patient Recruitment Platform that centralizes and standardizes all recruitment activities from every source, channel, and partner from interest through enrollment ? providing unprecedented transparency and actionable insights for real-time patient tracking, higher-quality referrals that reduce site burden, and robust ROI reporting. Honey is surrounded by a team of Precision Recruitment experts who meet patients where they are in their journey with data-driven modeling based on consumer behavior and other real-world data, hyper-targeted digital outreach, two-step pre-qualification, and meaningful Omnichannel partners focused on patient advocacy, community engagement, and diversity. To take control of patient recruitment for your next study, visit http://www.trialbee.com/.

Media Contact

Matt Magliozzo, Gregory FCA for Trialbee, 1 6102282096, [email protected], www.trialbee.com

Kristopher Sarajian, Trialbee, [email protected], Trialbee

SOURCE Trialbee


These press releases may also interest you

at 11:30
Top-tier VR accessories provider KIWI design has launched its latest product, the RGB Vertical Stand. This Meta-authorized accessory, designed to deepen users' immersion in the metaverse, is now available on the official Meta website....

at 10:45
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

at 10:31
On May 9, The 8th Global ICT Energy Efficiency Summit, themed "Green Site, Building a Brighter Future", was held in Bangkok, Thailand. At this summit, Site Power Facility Domain of Huawei Digital Power launched the All-Scenario Smart Telecom Power...

at 09:05
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...

at 09:00
From May 7th to May 9th, 2024, TCT ASIA 2024 was held at the National Exhibition and Convention Center in Shanghai. As a global summit for 3D printing technology, this exhibition brought together numerous industry elites and research experts to...

at 08:00
The ninth annual United Nations Science, Technology, and Innovation Forum (UN STI Forum), dedicated to advancing the Sustainable Development Goals, convened at the UN headquarters in New York on May 9-10, 2024. Under the theme "Science, Technology,...



News published on and distributed by: